Skip to main content
. Author manuscript; available in PMC: 2008 Apr 1.
Published in final edited form as: J Neuroimmunol. 2007 Feb 27;185(1-2):168–174. doi: 10.1016/j.jneuroim.2007.01.011

Table 2(A).

Changes in Serum and Cellular Cytokine levels over 24 weeks of IFN-beta qw (n=8)

pg/ml mean±SE Pre-Rx mean 4 weeks 8 Weeks 12 weeks 16 Weeks 20 weeks 24 weeks Post-Rx mean
Serum IL10 13.36±1.31 13.49±1.17 13.45±1.43 13.57±1.73 14.21±2.00 12.27±1.02 12.51±0.71 13.05±0.56
Serum IL12p70 53.71±8.36 56.80±4.57 50.77±6.19 45.22±7.69 46.93±9.43 41.52±5.67 47.89±5.77 48.19±2.69*
Serum 10/12p70 0.253 ± 0.023 0.228 ± 0.0274 0.288 ± 0.044 0.329 ± 0.039 0.330 ± 0.035 0.318 ± 0.027 0.287 ± 0.035 0.297±0.014
cellular IL10 424.8±125.5 330.3±59.06 336.2±100.4 1062±351.0 758.8±225.0 1249±553.7 547.6±111.7 713.9±123.1
cellular IL12p40 1299±282.3 1266±450.3 1120±384.6 1381±321.6 1164±215.7 811.1±179.5 1028±177.6 1128±121.2
cellular IL12p70 63.77±22.89 72.10±28.10 23.86±12.14 108.1±56.86 55.29±15.90 62.33±26.16 21.99±4.457 57.27±12.07
cellular IFN-g 845.8±261.2 417.1±307.0 239.2±97.97 221.4±54.02 194.5±67.42 299.5±104.4 341.2±154.0 285.5±61.21

†=value significantly different vs. pre-treatment (p<0.05 by repeated measures ANOVA)

*=value significantly different vs tiw (p<0.05 by Mann-Whitney)